Neuroendocrine bronchial and thymic tumors: ESMO clinical recommendation for diagnosis, treatment and follow-up

Annals of Oncology

Volumn 20, Issue SUPPL. 4, 2009, Pages

  Oberg, K ^a   Jelic, S ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CHROMOGRANIN A; CISPLATIN; CORTICOTROPIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GROWTH HORMONE RELEASING FACTOR; HYDROCORTISONE; NEURON SPECIFIC ENOLASE; SOMATOMEDIN C; SOMATOSTATIN RECEPTOR; SYNAPTOPHYSIN; VINCRISTINE;

ARTICLE; BRONCHOSCOPY; BRONCHUS BIOPSY; BRONCHUS CARCINOID; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PALLIATIVE THERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPIC ECHOGRAPHY; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SURVIVAL TIME; THYMOMA;

BRONCHIAL NEOPLASMS; EUROPE; FOLLOW-UP STUDIES; HEALTH PLANNING GUIDELINES; HUMANS; NEUROENDOCRINE TUMORS; THYMUS NEOPLASMS; TREATMENT OUTCOME;

EID: 66549115635     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdp157     Document Type: Article

References (7)

1. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003; 97: 934-959.
2. Soga J, Yakuwa Y, Osaka M. Evaluation of 342 cases of mediastinal/thymic carcinoids collected from literature: A comparative study between typical carcinoids and atypical varieties. Ann Thorac Cardiovasc Surg 1999; 5: 285-292.
3. Fink G, Krelbaum T, Yellin A et al. Pulmonary carcinoid: Presentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the literature. Chest 2001; 119: 1647-1651.
4. Granberg D, Wilander E, Oberg K et al. Prognostic markers in patients with typical bronchial carcinoid tumors. J Clin Endocrinol Metab 2000; 85: 3425-3430.
5. Ricke J, Klose KJ, Mignon M et al. Standardisation of imaging in neuroendocrine tumours: Results of a European delphi process. Eur J Radiol 2001; 37: 8-17.
6. Oberg K. Chemotherapy and biotherapy in the treatment of neuroendocrine tumours. Ann Oncol 2001; 12 (Suppl 2): S111-S114.
7. Kwekkeboom D, Krenning EP, de Jong M. Peptide receptor imaging and therapy. J Nucl Med 2000; 41: 1704-1713.